Search Results - "Wohlfeil, Stefan"

Inhibition of human hepatitis B virus (HBV) by a novel non-nucleosidic compound in a transgenic mouse model by Weber, O., Schlemmer, K.-H., Hartmann, E., Hagelschuer, Ina, Paessens, A., Graef, E., Deres, K., Goldmann, S., Niewoehner, U., Stoltefuss, J., Haebich, D., Ruebsamen-Waigmann, H., Wohlfeil, Stefan

“…BAY 41-4109 is a member of a class of heteroaryl-pyrimidines that was recently identified as potent inhibitors of human hepatitis B virus (HBV) replication. We…”
Get full text

Reported Severe Hypersensitivity Reactions after Intravenous Iron Administration in the European Economic Area (EEA) Before and After Implementation of Risk Minimization Measures by Nathell, Lennart, Gohlke, Annegret, Wohlfeil, Stefan

“…Introduction Severe hypersensitivity reactions (HSRs) such as anaphylaxis are of great clinical concern because of their life-threatening potential. The…”
Get full text

Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron (III) Isomaltoside 1000 in Europe Based on Data from EudraVigilance and VigiBase™ between 2014 and 2017 by Ehlken, Birgit, Nathell, Lennart, Gohlke, Annegret, Bocuk, Derya, Toussi, Massoud, Wohlfeil, Stefan

“…Introduction Hypersensitivity reactions (HSRs) are among the known adverse events of intravenous (i.v.) iron products. Of these, particularly severe HSRs such…”
Get full text

A comment on the comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia by Mundy, Linda M., Wohlfeil, Stefan

Get full text

Authors’ reply to Schaffalitzky de Muckadell and colleague’s Comment on “Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron (III) Isomaltoside 1000 in Europe Based on Data from EudraVigilance and VigiBase™ between 2014 and 2017” by Ehlken, Birgit, Nathell, Lennart, Gohlke, Annegret, Bocuk, Derya, Toussi, Massoud, Wohlfeil, Stefan

“…We appreciate the interest the manufacturer, Pharmacosmos, has in the details of the published analysis. However, we take issue with and wholly disagree with…”
Get full text

Involvement of 15-lipoxygenase in early stages of atherogenesis by KÜHN, H, BEKLNER, J, ZAISS, S, FÄHRENKLEMPER, T, WOHLFEIL, S

“…The arachidonate 15-lipoxygenase which is expressed in atherosclerotic lesions is implicated in the oxidative modification of low density lipoproteins during…”
Get full text

Comparison of the Effects of the Thrombin Inhibitor r-Hirudin in Four Animal Models of Neointima Formation After Arterial Injury by Gerdes, Christoph, Faber-Steinfeld, Verona, Yalkinoglu, Ozkan, Wohlfeil, Stefan

“…Thrombin has been implicated as a contributing factor to restenosis after vessel reopening procedures. We compared the ability of the direct thrombin inhibitor…”
Get full text

Effect of protein kinase inhibitors on ACTH-stimulated aldosterone production in rat zona glomerulosa cells by Kurscheid-Reich, D, Hegemann, L, Wohlfeil, S

“…In order to obtain further evidence for the involvement of protein kinases in the short-term ACTH-stimulated aldosterone synthesis in rat zona glomerulosa…”
Get more information

The elevation of cyclic GMP as a response to acute hypervolemia is blocked by a monoclonal antibody directed against atrial natriuretic peptides by Stasch, J P, Hirth, C, Kazda, S, Wohlfeil, S

“…Substantial volume expansion in conscious rats induces a strong diuresis and natriuresis that is caused by the increase in plasma levels of atrial natriuretic…”
Get more information